Summit Therapeutics (SMMT) Exchange Rate Effect (2016 - 2026)
Summit Therapeutics filings provide 13 years of Exchange Rate Effect readings, the most recent being -$19000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 150.0% to -$19000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Mar 2026, down 19.64% year-over-year, with the annual reading at $102000.0 for FY2025, 666.67% up from the prior year.
- Exchange Rate Effect hit -$19000.0 in Q1 2026 for Summit Therapeutics, roughly flat from -$19000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2022 and bottomed at -$1.8 million in Q3 2022.
- Average Exchange Rate Effect over 5 years is -$18705.9, with a median of $12000.0 recorded in 2024.
- Peak annual rise in Exchange Rate Effect hit 428.16% in 2022, while the deepest fall reached 621.74% in 2022.
- Summit Therapeutics' Exchange Rate Effect stood at $1.4 million in 2022, then tumbled by 80.22% to $272000.0 in 2023, then tumbled by 139.71% to -$108000.0 in 2024, then soared by 82.41% to -$19000.0 in 2025, then changed by 0.0% to -$19000.0 in 2026.
- Per Business Quant, the three most recent readings for SMMT's Exchange Rate Effect are -$19000.0 (Q1 2026), -$19000.0 (Q4 2025), and $22000.0 (Q3 2025).